Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
Uchenna Elenwa
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
520Citations signalées
0Affiliations récentes
Domaines associés
COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and MechanismsAdrenal Hormones and DisordersSARS-CoV-2 and COVID-19 Research
Publications récentes
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jaffar Abbas et autres
3 citationsEClinicalMedicine
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Sandercock, Janet Darbyshire, David L. DeMets, Robert Fowler et autres
11 citationsNature Communications
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, Natalie Staplin et autres
40 citationsThe Lancet Child & Adolescent Health
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
132 citationsThe Lancet
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
334 citationsThe Lancet
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.